Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hypertrophy, Right Ventricular D017380 4 associated lipids
Strongylida Infections D017206 5 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Liver Failure D017093 5 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Corneal Neovascularization D016510 8 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Helicobacter Infections D016481 21 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
HIV Infections D015658 20 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Borin ML et al. [Relation between the changes in Na+/H+-exchange and cytoplasmic Ca levels in platelet activation]. 1988 Biull Eksp Biol Med pmid:2844320
Joseph R et al. Cytosolic ionized calcium homeostasis in platelets: an abnormal sensitivity to PAF-activation in migraine. 1988 Headache pmid:2844693
Smith SK and Kelly RW Effect of platelet-activating factor on the release of PGF-2 alpha and PGE-2 by separated cells of human endometrium. 1988 J. Reprod. Fertil. pmid:3422322
Arnoux B et al. Effect of PAF-acether in non-human primates. 1988 Prog. Clin. Biol. Res. pmid:2837781
Livio M et al. Role of platelet-activating factor in primary hemostasis. 1988 Am. J. Physiol. pmid:2837916
Criscuoli M and Subissi A Catecholamines released from the adrenal medulla exert a compensatory, protective effect at beta 2-adrenoceptors against Paf-induced death in mice. 1988 Br. J. Pharmacol. pmid:2894872
Bekker AY et al. Dose-response relationships between platelet activating factor and permeability--surface area product of FITC-dextran 150 in the hamster cheek pouch. 1988 Microcirc Endothelium Lymphatics pmid:2475751
Vivier E et al. Immunoregulatory functions of paf-acether. II. Decrease of CD2 and CD3 antigen expression. 1988 Eur. J. Immunol. pmid:2895712
Hoffman DR et al. Synthesis of platelet activating factor by cholinephosphotransferase in developing fetal rabbit lung. 1988 Lipids pmid:2897059
Leff AR Neurohumoral regulation of airway contractile responses. 1988 Chest pmid:2897271
Nasmith PE and Grinstein S Cytosolic calcium, oxygen consumption and the intracellular pH of stimulated neutrophils. 1988 Biosci. Rep. pmid:2840131
Altin JG and Bygrave FL Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor. 1988 Biochem. J. pmid:3128268
Bochner BS et al. Adherence of human basophils to cultured umbilical vein endothelial cells. 1988 J. Clin. Invest. pmid:3130394
Crouch MF and Lapetina EG No direct correlation between Ca2+ mobilization and dissociation of Gi during platelet phospholipase A2 activation. 1988 Biochem. Biophys. Res. Commun. pmid:3132162
Russell JA et al. Changes in the levels of bioactive components of cotton bracts accompanying senescence. 1988 Lung pmid:3132575
Martins MA et al. Intravenous injections of PAF-acether induce platelet aggregation in rats. 1988 Eur. J. Pharmacol. pmid:3135199
Peers SH Dexamethasone inhibits platelet activating factor-induced inflammation in the paw but not the pleural cavity of rats. 1988 Eur. J. Pharmacol. pmid:3136026
Valone FH and Epstein LB Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma. 1988 J. Immunol. pmid:3141509
Berti F et al. New pharmacological data on the bronchospasmolytic activity of bamifylline. 1988 Arzneimittelforschung pmid:3365275
Sun XM and Hsueh W Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. 1988 J. Clin. Invest. pmid:3366898
Rydzewska G and Gabryelewicz A [Platelet activating factor (PAF) and its inhibitors]. 1988 Pol. Arch. Med. Wewn. pmid:2482481
Shalit M et al. Platelet activating factor increases expression of complement receptors on human neutrophils. 1988 J. Leukoc. Biol. pmid:2842423
Jouquey S et al. Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat. 1988 Agents Actions pmid:2459935
Lichterfeld A et al. [Platelet activating factor and its possible role in bronchial asthma]. 1988 Prax Klin Pneumol pmid:3041401
Rosenthal MD et al. Esterification of 8,11,14-eicosatrienoate and arachidonate into alkylacyl- and diacylglycerophosphocholine by vascular endothelial cells. 1988 Lipids pmid:3148797
Mullane KM et al. Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion. 1988 Ann. N. Y. Acad. Sci. pmid:2837948
Barnes PJ Inflammatory mechanisms and nocturnal asthma. 1988 Am. J. Med. pmid:3041827
Goodwin JS and Behrens T Role of lipoxygenase metabolites of arachidonic acid in T cell activation. 1988 Ann. N. Y. Acad. Sci. pmid:2837956
Camussi G and Salvidio G Platelet-activating factor in graft rejection. 1988 Prog Biochem Pharmacol pmid:3043426
Hénocq E PAF-acether and eosinophils. 1988 Prog Biochem Pharmacol pmid:3043428
Lagente V and Fortes ZB Role of PAF-acether in the vascular events of inflammation. 1988 Prog Biochem Pharmacol pmid:3043429
Abraham WM The role of leukotrienes in allergen-induced late responses in allergic sheep. 1988 Ann. N. Y. Acad. Sci. pmid:2837960
Lazanas M et al. PAF of biological fluids in disease: IV. Levels in blood in allergic reactions induced by drugs. 1988 Arch. Dermatol. Res. pmid:3395143
Cordeiro RS et al. Proinflammatory activity of platelet-activating factor: pharmacological modulation and cellular involvement. 1988 Prog Biochem Pharmacol pmid:3043430
Satoh K et al. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. 1988 Prostaglandins pmid:3399678
Mazière JC et al. PAF-acether decreases low density lipoprotein degradation and alters lipid metabolism in cultured human fibroblasts. 1988 FEBS Lett. pmid:3402608
There is a case for PAF-acether antagonists. Abstracts of the conference. Paris, France, May 25-27, 1988. 1988 Prostaglandins pmid:3399682
Valone FH Platelet-activating factor binding and metabolism during human platelet aggregation. 1988 Thromb. Res. pmid:3400077
Bratton DL et al. Effects of platelet activating factor on calcium-lipid interactions and lateral phase separations in phospholipid vesicles. 1988 Biochim. Biophys. Acta pmid:3401478
Evans TW et al. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man. 1988 Br. J. Pharmacol. pmid:3401633
Lagente V et al. Interference of the Paf antagonist Ro 19-3704 with Paf and antigen-induced bronchoconstriction in the guinea-pig. 1988 Br. J. Pharmacol. pmid:3401641
Pirotzky E and Braquet P [The role of the platelet-activating factor (PAF-acether) in renal pathology]. 1988 Presse Med pmid:2966954
Willuweit B and Aktories K Heparin and heparinoids impair adrenaline and platelet-activating factor but not thrombin-induced inhibition of adenylate cyclase and stimulation of GTP hydrolysis in human platelet membranes. 1988 Naunyn Schmiedebergs Arch. Pharmacol. pmid:2969081
Rosario-Jansen T et al. Phospholipids chiral at phosphorus. Synthesis and stereospecificity of phosphorothioate analogues of platelet-activating factor. 1988 Biochemistry pmid:3167004
Prévost MC et al. Possible origins of PAF-acether and lyso-PAF-acether in rat lung alveoli secondary to hypoxia. 1988 Biochim. Biophys. Acta pmid:3167085
Nagpurkar A et al. Effect of rat phosphorylcholine-binding protein on platelet aggregation. 1988 Biochim. Biophys. Acta pmid:3167098
Wallace JL Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. 1988 Can. J. Physiol. Pharmacol. pmid:3167675
Stenson WF Platelet-activating factor and inflammatory bowel disease. 1988 Gastroenterology pmid:3169505
Valone FH et al. Enhanced human monocyte cytotoxicity by platelet-activating factor. 1988 Immunology pmid:3169845
Popovich KJ et al. Role of platelets in contraction of canine tracheal muscle elicited by PAF in vitro. 1988 J. Appl. Physiol. pmid:3170437
Bonventre JV et al. PAF and PDGF increase cytosolic [Ca2+] and phospholipase activity in mesangial cells. 1988 Am. J. Physiol. pmid:3337246
Weisman SM et al. Differential effect of platelet-activating factor (PAF) receptor antagonists on peptide and PAF-stimulated prostaglandin release in unilateral ureteral obstruction. 1988 Biochem. Pharmacol. pmid:2840083
Wallace JL and Whittle BJ Gastrointestinal damage induced by platelet-activating factor. Inhibition by the corticoid, dexamethasone. 1988 Dig. Dis. Sci. pmid:3338370
Benveniste J et al. Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins. 1988 FEBS Lett. pmid:3338565
Lagente V et al. Involvement of PAF-acether in anaphylactic bronchoconstriction induced in guinea pigs by aerosolized antigen. 1988 Int. Arch. Allergy Appl. Immunol. pmid:3338855
Kochanek PM et al. Cerebrovascular and cerebrometabolic effects of intracarotid infused platelet-activating factor in rats. 1988 J. Cereb. Blood Flow Metab. pmid:3392115
Imai T et al. Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021. 1988 J. Lab. Clin. Med. pmid:3339274
Wichrowski B et al. Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres. 1988 J. Med. Chem. pmid:3339611
Michel L et al. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro. 1988 J. Immunol. pmid:3397536
Tilley JW et al. Pyrido[2,1-b]quinazolinecarboxamide derivatives as platelet activating factor antagonists. 1988 J. Med. Chem. pmid:3339617
Ferguson MK et al. Lymphatic smooth muscle responses to leukotrienes, histamine and platelet activating factor. 1988 J. Surg. Res. pmid:3339877
Hellegouarch A et al. Lack of effect of atrial natriuretic factor on the tone induced in rat portal vein by platelet-activating factor. 1988 Eur. J. Pharmacol. pmid:2832190
Valone FH Identification of platelet-activating factor receptors in P388D1 murine macrophages. 1988 J. Immunol. pmid:2832476
Homma H and Hanahan DJ Attenuation of platelet activating factor (PAF)-induced stimulation of rabbit platelet GTPase by phorbol ester, dibutyryl cAMP, and desensitization: concomitant effects on PAF receptor binding characteristics. 1988 Arch. Biochem. Biophys. pmid:2833174
Huang SJ et al. Platelet-activating factor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate stimulates the production of reactive oxygen intermediates in macrophages. 1988 Biochem. J. pmid:2833227
Rees RS et al. Plasma components are required for platelet activation by the toxin of Loxosceles reclusa. 1988 Toxicon pmid:3245050
Brass LF et al. Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase. 1988 J. Biol. Chem. pmid:2833506
Blank ML et al. Stimulation of the de novo pathway for the biosynthesis of platelet-activating factor (PAF) via cytidylyltransferase activation in cells with minimal endogenous PAF production. 1988 J. Biol. Chem. pmid:2833508
Mencia-Huerta JM et al. [Effect of long-term administration of platelet activating factor on pulmonary response and morphology in the guinea pig]. 1988 Allerg Immunol (Paris) pmid:3245884
Rola-Pleszczynski M et al. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells. 1988 J. Immunol. pmid:2834440
Takeuchi N et al. The antagonist effects of compounds derived from khellactone on platelet-activating factor. 1988 Chem. Pharm. Bull. pmid:3245999
Kimani G et al. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. 1988 J. Immunol. pmid:3361129
Hofmann B et al. Effect of specific antagonists on PAF-induced platelet aggregation and release of plasminogen activator. 1988 Biomed. Biochim. Acta pmid:3248103
Robertson DA et al. Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity. 1988 J. Pharmacol. Exp. Ther. pmid:3361438
Mest HJ et al. The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids. 1988 Biomed. Biochim. Acta pmid:3248107
Terashita Z et al. Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lung. 1988 Biochem. Pharmacol. pmid:2839198
Prpic V et al. Biochemical and functional responses stimulated by platelet-activating factor in murine peritoneal macrophages. 1988 J. Cell Biol. pmid:2839520
Kroegel C The potential pathophysiological role of platelet-activating factor in human diseases. 1988 Klin. Wochenschr. pmid:2839728
Hammerschmidt DE et al. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor. 1988 J. Lab. Clin. Med. pmid:2840477
Hwang SB et al. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor. 1988 J. Pharmacol. Exp. Ther. pmid:2841449
Parnham MJ PAF receptors. 1988 Prog Biochem Pharmacol pmid:2841664
Shkhvatsabaia IK et al. [Receptor-dependent regulation of the concentration of Ca2+ in the cytoplasm of thrombocytes in hypertensive patients]. 1988 Kardiologiia pmid:2842537
Plante GE et al. Platelet activating factor antagonism with BN52021 protects the kidney against acute ischemic injury. 1988 Prostaglandins Leukot. Essent. Fatty Acids pmid:3231663
Stephens LR et al. Synthesis of myo-inositol 1,3,4,5,6-pentakisphosphate from inositol phosphates generated by receptor activation. 1988 Biochem. J. pmid:2845930
Santos JC et al. Effect of intrarenal infusion of synthetic PAF-acether in dogs. 1988 Rev. Esp. Fisiol. pmid:3231880
Ukena D and Sybrecht GW [Function of platelet activating factor in asthma]. 1988 Dtsch. Med. Wochenschr. pmid:2846251
Ostermann G et al. The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients. 1988 Thromb. Res. pmid:3232123
Ng DS and Wong K Effect of sulfhydryl reagents on PAF binding to human neutrophils and platelets. 1988 Eur. J. Pharmacol. pmid:2846326
Avdonin PV et al. Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine. 1988 Thromb. Res. pmid:3232128
Storch J et al. Influence of platelet activating factor and a nonmetabolizable analogue on superoxide production by bone marrow derived macrophages. 1988 J. Leukoc. Biol. pmid:2846728
Kiktev VG et al. [Calcium metabolism of the thrombocytes in ischemic heart disease]. 1988 Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR pmid:3233156
Bussolino F et al. Acetylcholine and dopamine promote the production of platelet activating factor in immature cells of chick embryonic retina. 1988 J. Neurochem. pmid:2846783
Yamada K et al. Highly sensitive gas chromatographic--mass spectrometric method for the determination of platelet-activating factor in human blood. 1988 J. Chromatogr. pmid:3235552
Birkle DL et al. Platelet-activating factor antagonist BN52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock. 1988 J. Neurochem. pmid:2846788
Yoshikawa D and Goto F [Interactions between platelet activating factor and leukotrienes during endotoxin shock in the rat]. 1988 Masui pmid:3236398
Altman R et al. Why single daily dose of aspirin may not prevent platelet aggregation. 1988 Thromb. Res. pmid:3140408
Rouis M et al. Platelet activating factor is a potent stimulant of the production of active oxygen species by human monocyte-derived macrophages. 1988 Biochem. Biophys. Res. Commun. pmid:2847729
Doni MG et al. Forskolin and prostacyclin inhibit fluoride induced platelet activation and protein kinase C dependent responses. 1988 Biochem. Biophys. Res. Commun. pmid:2847730
Piper PJ et al. Release of leukotrienes from porcine and human blood vessels by immunological and nonimmunological stimuli. 1988 Ann. N. Y. Acad. Sci. pmid:2837950
Rubin RM et al. Prostaglandin-independent inhibition of ocular vascular permeability by a platelet-activating factor antagonist. 1988 Arch. Ophthalmol. pmid:3261165